Venrock Adviser, LLC — 13F Holdings & Portfolio
CIK 1615982 · latest 13F-HR filed 2026-05-15
Venrock Adviser, LLC manages $2.68B in 13F-reported U.S. long-equity assets across 33 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are APGE (26.68%), ERAS (9.89%), ORKA (7.60%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 8 new positions, exited 2, added to 15, and trimmed 9.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$2.68B
Long-equity book
33
Distinct positions
2026-03-31
Filed 2026-05-15
+8 / −2 / ↑15 / ↓9
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ERASCA INC$198.6M +299.0%
- ORUKA THERAPEUTICS INC$77.7M +61.8%
- APOGEE THERAPEUTICS INC$73.8M +11.5%
- SPYRE THERAPEUTICS INC$65.2M +54.0%
- DIANTHUS THERAPEUTICS INC$57.8M +140.3%
Top Trims
- VIRIDIAN THERAPEUTICS INC-$44.9M -37.1%
- CYTOMX THERAPEUTICS INC-$19.4M -29.2%
- MAZE THERAPEUTICS INC-$16.3M -25.5%
- CYBIN INC-$12.9M -41.1%
- ENGENE HOLDINGS INC-$10.6M -24.6%
New Positions
- DAMORA THERAPEUTICS INC$93.3M
- RELMADA THERAPEUTICS INC$33.7M
- TENAX THERAPEUTICS INC$26.8M
- ADLAI NORTYE LTD$22.2M
- CENTURY THERAPEUTICS INC$19.7M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $714.9M | 26.68% | 8,493,321 | SH |
| 2 | ERASCA INC | ERAS | 29479A108 | $265.1M | 9.89% | 16,382,812 | SH |
| 3 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $203.5M | 7.60% | 4,148,428 | SH |
| 4 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $185.9M | 6.94% | 3,685,448 | SH |
| 5 | KALVISTA PHARMACEUTICALS INC | KALV | 483497103 | $130.3M | 4.86% | 6,474,485 | SH |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $99.0M | 3.70% | 1,180,000 | SH |
| 7 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $93.3M | 3.48% | 3,603,595 | SH |
| 8 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $87.6M | 3.27% | 10,346,926 | SH |
| 9 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $77.0M | 2.87% | 2,000,000 | SH |
| 10 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $75.9M | 2.83% | 3,882,709 | SH |
| 11 | SAVARA INC | SVRA | 805111101 | $75.0M | 2.80% | 13,740,375 | SH |
| 12 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $67.7M | 2.53% | 1,726,331 | SH |
| 13 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $54.7M | 2.04% | 4,319,765 | SH |
| 14 | VOR BIOPHARMA INC | VOR | 929033207 | $54.3M | 2.03% | 3,041,719 | SH |
| 15 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $47.8M | 1.78% | 1,602,034 | SH |
| 16 | CYTOMX THERAPEUTICS INC | CTMX | 23284F105 | $46.9M | 1.75% | 9,982,124 | SH |
| 17 | JADE BIOSCIENCES INC | JBIO | 008064206 | $45.2M | 1.69% | 3,220,364 | SH |
| 18 | DYNE THERAPEUTICS INC | DYN | 26818M108 | $39.4M | 1.47% | 2,173,913 | SH |
| 19 | CRESCENT BIOPHARMA INC. | CBIO | G2545C104 | $39.2M | 1.46% | 2,133,576 | SH |
| 20 | ZURA BIO LTD | ZURA | G9TY5A101 | $38.3M | 1.43% | 6,434,990 | SH |
| 21 | RELMADA THERAPEUTICS INC | RLMD | 75955J402 | $33.7M | 1.26% | 4,843,380 | SH |
| 22 | ENGENE HOLDINGS INC | ENGNW | 29286M105 | $32.5M | 1.21% | 4,771,414 | SH |
| 23 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $26.8M | 1.00% | 1,675,262 | SH |
| 24 | ADLAI NORTYE LTD | ANL | 00704R109 | $22.2M | 0.83% | 3,212,731 | SH |
| 25 | CENTURY THERAPEUTICS INC | IPSC | 15673T100 | $19.7M | 0.73% | 8,695,652 | SH |
| 26 | CULLINAN THERAPEUTICS INC | CGEM | 230031106 | $19.6M | 0.73% | 1,379,965 | SH |
| 27 | CYBIN INC | HELP | 23256X407 | $18.5M | 0.69% | 3,851,654 | SH |
| 28 | SURROZEN INC | SRZN | 86889P208 | $18.4M | 0.69% | 632,931 | SH |
| 29 | SEPTERNA INC | SEPN | 81734D104 | $12.2M | 0.45% | 506,056 | SH |
| 30 | KORRO BIO INC | KRRO | 500946108 | $11.4M | 0.43% | 1,009,500 | SH |
| 31 | ALTO NEUROSCIENCE INC | ANRO | 02157Q109 | $11.2M | 0.42% | 500,000 | SH |
| 32 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 04317A107 | $10.4M | 0.39% | 1,609,569 | SH |
| 33 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $1.4M | 0.05% | 330,525 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $2.68B | 33 | 0001615982-26-000011 |
| 2025-12-31 | 2026-02-17 | $2.02B | 27 | 0001615982-26-000005 |
| 2025-09-30 | 2025-11-14 | $1.78B | 33 | 0001615982-25-000006 |